We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

202 hedge funds and large institutions have $3.5B invested in Medicines Co in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 90 increasing their positions, 66 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more call options, than puts

Call options by funds: $114M | Put options by funds: $73.8M

36% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 66

8% less funds holding

Funds holding: 220 → 202 (-18)

14% less funds holding in top 10

Funds holding in top 10: 14 → 12 (-2)

22% less capital invested

Capital invested by funds: $4.52B → $3.5B (-$1.02B)

43% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 37

Holders
202
Holders Change
-18
Holders Change %
-8.18%
% of All Funds
5.04%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.3%
New
21
Increased
90
Reduced
66
Closed
37
Calls
$114M
Puts
$73.8M
Net Calls
+$40.1M
Net Calls Change
+$16.3M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$81.8M
2
PI
Putnam Investments
Massachusetts
+$37.4M
3
IAM
Iridian Asset Management
Connecticut
+$29.2M
4
BM
Bridger Management
New York
+$28.6M
5
Deutsche Bank
Deutsche Bank
Germany
+$16.9M

Top Sellers

Rank Fund Capital Flow
1
BRC
Blue Ridge Capital
New York
-$53.8M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$48.8M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$39.6M
4
Invesco
Invesco
Georgia
-$32.6M
5
RI
RTW Investments
New York
-$28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
76
Wells Fargo
California
$4M +$997K +22,380 +27%
GC
77
Guggenheim Capital
Illinois
$3.66M +$854K +19,171 +25%
Allianz Asset Management
78
Allianz Asset Management
Germany
$3.65M -$52.1K -1,170 -1%
Group One Trading
79
Group One Trading
Illinois
$3.56M +$857K +19,242 +26%
CS
80
Candriam SCA
Luxembourg
$3.42M +$579K +13,000 +17%
LPC
81
Lion Point Capital
New York
$3.31M +$3.87M +87,001 New
Comerica Bank
82
Comerica Bank
Texas
$2.98M -$168K -3,768 -5%
USAA
83
United Services Automobile Association
Texas
$2.61M +$107K +2,400 +4%
NFA
84
Nationwide Fund Advisors
Ohio
$2.59M -$557K -12,510 -16%
State of Tennessee, Department of Treasury
85
State of Tennessee, Department of Treasury
Tennessee
$2.54M +$74.6K +1,675 +3%
American Century Companies
86
American Century Companies
Missouri
$2.34M -$315K -7,081 -10%
MOACM
87
Mutual of America Capital Management
New York
$2.23M -$90.6K -2,034 -3%
PI
88
PineBridge Investments
New York
$2.13M +$573K +12,874 +30%
UBS Group
89
UBS Group
Switzerland
$2.1M +$295K +6,631 +14%
CS
90
Credit Suisse
Switzerland
$2.03M -$1.41M -31,767 -37%
Manulife (Manufacturers Life Insurance)
91
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.02M +$46K +1,033 +2%
Millennium Management
92
Millennium Management
New York
$2.01M +$2.36M +52,987 New
TPSF
93
Texas Permanent School Fund
Texas
$2M +$45K +1,010 +2%
AIG
94
American International Group
New York
$1.98M +$503K +11,291 +28%
State of Wisconsin Investment Board
95
State of Wisconsin Investment Board
Wisconsin
$1.98M +$2.32M +52,000 New
TF
96
TIAA FSB
Florida
$1.92M +$2.24M +50,383 New
CC
97
Clearline Capital
New York
$1.88M +$2.2M +49,342 New
IAS
98
IMA Advisory Services
Colorado
$1.86M -$76.6K -1,719 -3%
Retirement Systems of Alabama
99
Retirement Systems of Alabama
Alabama
$1.76M – – –
MLICM
100
Metropolitan Life Insurance Company (MetLife)
New York
$1.76M +$8.82K +198 +0.4%
2 3
4
5 6

MDCO Hedge Fund Activity: Q2 2017 in Review

202 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q2 2017, worth a combined $3.5B — down 22% from $4.52B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of MDCO and 21 opened new positions — a net loss of 16 holders — while 66 trimmed existing stakes and 90 added.

The largest buyer was Westfield Capital Management, adding an estimated $81.8M. The largest seller was Blue Ridge Capital, exiting entirely with an estimated $53.8M sold.

  • 202 institutional investors held Medicines Co (MDCO) as of Q2 2017, down from 220 in Q1 2017.
  • Funds reported $3.5B of Medicines Co stock for Q2 2017, down 22% quarter-over-quarter.
  • 21 funds opened new Medicines Co positions in Q2 2017 and 37 closed out, a net change of -16 holders.
  • The largest Medicines Co buyer in Q2 2017 was Westfield Capital Management, an estimated $81.8M added.
  • The largest Medicines Co seller in Q2 2017 was Blue Ridge Capital, an estimated $53.8M sold.

Based on aggregated 13F filings for Q2 2017.